Pawelec G - Search Results

1

Impact of age, sex and CMV-infection on peripheral T cell phenotypes: results from the Berlin BASE-II Study.

Di Benedetto S, Derhovanessian E, Steinhagen-Thiessen E, Goldeck D, Müller L, Pawelec G. Di Benedetto S, et al. Among authors: pawelec g. Biogerontology. 2015 Oct;16(5):631-43. doi: 10.1007/s10522-015-9563-2. Epub 2015 Mar 3. Biogerontology. 2015. PMID: 25732234

2

Escape mechanisms in tumor immunity: a year 2000 update.

Pawelec G, Heinzel S, Kiessling R, Müller L, Ouyang Q, Zeuthen J. Pawelec G, et al. Crit Rev Oncog. 2000;11(2):97-133. Crit Rev Oncog. 2000. PMID: 11005508 Review.

3

Recognition of chronic myelogenous leukaemia cells by autologous T lymphocytes primed in vitro against the patient's dendritic cells.

Müller L, Provenzani C, Faul C, Pawelec G. Müller L, et al. Among authors: pawelec g. Br J Haematol. 2001 Mar;112(3):740-8. doi: 10.1046/j.1365-2141.2001.02596.x. Br J Haematol. 2001. PMID: 11260079 Free article.

4

MHC class II-restricted tumor antigens and CD4+ T cells play a role in hematological malignancies as well as solid tumors.

Pawelec G, Müller L, Wagner W. Pawelec G, et al. Trends Immunol. 2001 Aug;22(8):422-3. doi: 10.1016/s1471-4906(01)01987-1. Trends Immunol. 2001. PMID: 11491092 No abstract available.

5

Longevity in vitro of human CD4+ T helper cell clones derived from young donors and elderly donors, or from progenitor cells: age-associated differences in cell surface molecule expression and cytokine secretion.

Pawelec G, Mariani E, Bradley B, Solana R. Pawelec G, et al. Biogerontology. 2000;1(3):247-54. doi: 10.1023/a:1010086229931. Biogerontology. 2000. PMID: 11707901

6

Generation of chronic myelogenous leukemia-specific T cells in cytokine-modified autologous mixed lymphocyte/tumor cell cultures.

Müller L, Provenzani C, Pawelec G. Müller L, et al. Among authors: pawelec g. J Immunother. 2001 Nov-Dec;24(6):482-92. doi: 10.1097/00002371-200111000-00005. J Immunother. 2001. PMID: 11759071

7

Progress in vaccination against cancer (PIVAC) 2001, Robinson College, University of Cambridge, UK.

Rees RC, Pawelec G, Müller L, Robins A. Rees RC, et al. Among authors: pawelec g. Cancer Immunol Immunother. 2002 Mar;51(1):58-61. doi: 10.1007/s00262-001-0252-4. Epub 2002 Jan 10. Cancer Immunol Immunother. 2002. PMID: 11845261 Free PMC article. No abstract available.

8

Prediction of an HLA-DR-binding peptide derived from Wilms' tumour 1 protein and demonstration of in vitro immunogenicity of WT1(124-138)-pulsed dendritic cells generated according to an optimised protocol.

Knights AJ, Zaniou A, Rees RC, Pawelec G, Müller L. Knights AJ, et al. Among authors: pawelec g. Cancer Immunol Immunother. 2002 Jul;51(5):271-81. doi: 10.1007/s00262-002-0278-2. Epub 2002 Apr 26. Cancer Immunol Immunother. 2002. PMID: 12070714 Free PMC article.

9

Immunogenicity of WT-1 peptides.

Knights AJ, Müller L, Pawelec G. Knights AJ, et al. Among authors: pawelec g. Cancer Immunol Immunother. 2002 Aug;51(6):349. doi: 10.1007/s00262-002-0303-5. Epub 2002 Jun 14. Cancer Immunol Immunother. 2002. PMID: 12111123 Free PMC article. No abstract available.

10

Chronic phase CML patients possess T cells capable of recognising autologous tumour cells.

Müller L, Pawelec G. Müller L, et al. Among authors: pawelec g. Leuk Lymphoma. 2002 May;43(5):943-51. doi: 10.1080/10428190290021687. Leuk Lymphoma. 2002. PMID: 12148904 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

570 results

Search Page